ID: ALA443667

Max Phase: Preclinical

Molecular Formula: C31H37FN4O11P2

Molecular Weight: 722.60

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)OCC(=O)Nc3ccc(CC(P(=O)(O)O)P(=O)(O)O)cc3)cn(C3CC3)c12

Standard InChI:  InChI=1S/C31H37FN4O11P2/c1-46-30-27-21(12-23(32)28(30)35-13-18-3-2-10-33-24(18)15-35)29(38)22(14-36(27)20-8-9-20)31(39)47-16-25(37)34-19-6-4-17(5-7-19)11-26(48(40,41)42)49(43,44)45/h4-7,12,14,18,20,24,26,33H,2-3,8-11,13,15-16H2,1H3,(H,34,37)(H2,40,41,42)(H2,43,44,45)/t18-,24+/m0/s1

Standard InChI Key:  CKBNRWGWLAZCFQ-MHECFPHRSA-N

Associated Targets(Human)

Serum 1292 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Bone 37 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serum 604 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 722.60Molecular Weight (Monoisotopic): 722.1918AlogP: 2.69#Rotatable Bonds: 11
Polar Surface Area: 216.96Molecular Species: ZWITTERIONHBA: 10HBD: 6
#RO5 Violations: 2HBA (Lipinski): 15HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.21CX Basic pKa: 9.44CX LogP: -0.57CX LogD: -2.67
Aromatic Rings: 3Heavy Atoms: 49QED Weighted: 0.12Np Likeness Score: -0.42

References

1. Tanaka KS, Houghton TJ, Kang T, Dietrich E, Delorme D, Ferreira SS, Caron L, Viens F, Arhin FF, Sarmiento I, Lehoux D, Fadhil I, Laquerre K, Liu J, Ostiguy V, Poirier H, Moeck G, Parr TR, Rafai Far A..  (2008)  Bisphosphonated fluoroquinolone esters as osteotropic prodrugs for the prevention of osteomyelitis.,  16  (20): [PMID:18815051] [10.1016/j.bmc.2008.09.010]

Source